Good News for EpiPen® Auto-Injector Users and Families!
Mylan today issued a statement announcing that it is taking immediate action to increase access to EpiPen® Auto-Injectors by expanding already existing programs in recognition of those patients who are facing the burden of higher out-of-pocket costs, reducing direct patient costs and increasing eligibility for patient assistance programs for uninsured and under-insured patients.
Outrageous
In an August 22, 2016, New York Times article, Tara Parker-Pope and Rachel Rabkin Peachman reported on the steep increase in the price of the EpiPen, a lifesaving injection device for people with severe allergies, and the outrage these price increases have caused with consumers and lawmakers.
